PRISM Imaging - TBI

PRISM Imaging stands at the forefront of Traumatic Brain Injury (TBI) and Chronic Traumatic Encephalopathy (CTE) treatment, offering FDA-approved (510K) techniques to enhance our understanding and approach to these conditions:

• Advanced Structural and Functional CNS Imaging: PRISM's cutting-edge imaging techniques capture, quantify, and analyze the complexities of the Central Nervous System (CNS), offering a more comprehensive understanding of TBI and CTE.
• Quantitative Assessment of TBI and CTE: Through quantitative measures, PRISM provides an objective assessment of these conditions, allowing for accurate diagnosis and treatment planning.
• Objective Evidence of TBI: Our methods yield hard data, offering objective evidence of TBI, which can be invaluable in guiding therapeutic strategies and validating patient experiences.
• Utility in Both Acute and Chronic TBI: PRISM's imaging capabilities can be leveraged in both acute and chronic stages of TBI, providing valuable insights across the continuum of the injury.
• Treatment Planning and Response Assessment: Beyond initial diagnosis, our techniques can be used to optimize treatment planning and follow-up assessments, aiding in evaluating the effectiveness of treatment responses.
• Applicable to Other Neurocognitive and Neurodegenerative Disorders: PRISM's advanced imaging is not limited to TBI and CTE. It can also be used to diagnose and monitor treatment responses in other neurocognitive and neurodegenerative disorders.

At PRISM, we are dedicated to harnessing advanced imaging technology to enhance the diagnosis, treatment, and monitoring of TBI, CTE, and other neurocognitive disorders.